HIRSCHMAN ORIN 13D and 13G filings for CAMP4 Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-21 10:34 am Sale |
2023-12-20 | 13G | CAMP4 Therapeutics Corporation CAMP |
HIRSCHMAN ORIN | 0 0.000% |
-101,215 (Position Closed) |
Filing |
| 2023-02-15 06:16 am Purchase |
2022-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP |
HIRSCHMAN ORIN | 101,215 6.400% |
5,563 (+5.82%) |
Filing |
| 2022-05-09 2:38 pm Purchase |
2022-05-04 | 13G | CAMP4 Therapeutics Corporation CAMP |
HIRSCHMAN ORIN | 95,652 6.100% |
95,652 (New Position) |
Filing |